FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

FDA approved Arexvy, the first RSV vaccine approved for use in the U.S. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV.

Read the full article here

Related Articles

DENGVAXIA

DENGVAXIA For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9…